Safety of SABA Monotherapy in Asthma Management: a Systematic Review and Meta-analysis.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 1, p. 133, doi. 10.1007/s12325-022-02356-2
- By:
- Publication type:
- Article
Works matching IS 0741238X AND DT 2023 AND VI 40 AND IP 1
Results: 27
1
2
Adherence, Persistence, Readmissions, and Costs in Medicaid Members with Schizophrenia or Schizoaffective Disorder Initiating Paliperidone Palmitate Versus Switching Oral Antipsychotics: A Real-World Retrospective Investigation.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 1, p. 349, doi. 10.1007/s12325-022-02354-4
- By:
- Publication type:
- Article
3
Projecting the Epidemiological and Economic Impact of Chronic Kidney Disease Using Patient-Level Microsimulation Modelling: Rationale and Methods of Inside CKD.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 1, p. 265, doi. 10.1007/s12325-022-02353-5
- By:
- Publication type:
- Article
4
European Physician Survey Characterizing the Clinical Pathway and Treatment Patterns of Patients Post-Myocardial Infarction.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 1, p. 233, doi. 10.1007/s12325-022-02344-6
- By:
- Publication type:
- Article
5
The Importance of Integrated Regulation Mechanism of Coronary Microvascular Function for Maintaining the Stability of Coronary Microcirculation: An Easily Overlooked Perspective.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 1, p. 76, doi. 10.1007/s12325-022-02343-7
- By:
- Publication type:
- Article
6
Correction to: Initiating or Switching to Insulin Degludec/Insulin Aspart in Adults with Type 2 Diabetes: A Real-World, Prospective, Non-interventional Study Across Six Countries.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
7
Future Directions in Research in Transcriptomics in the Healing of Diabetic Foot Ulcers.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 1, p. 67, doi. 10.1007/s12325-022-02348-2
- By:
- Publication type:
- Article
8
Examining the Systemic Bioavailability of Cannabidiol and Tetrahydrocannabinol from a Novel Transdermal Delivery System in Healthy Adults: A Single-Arm, Open-Label, Exploratory Study.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 1, p. 282, doi. 10.1007/s12325-022-02345-5
- By:
- Publication type:
- Article
9
Recurrence Rates and Pharmacological Treatment for Hemorrhoidal Disease: A Systematic Review.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 1, p. 117, doi. 10.1007/s12325-022-02351-7
- By:
- Publication type:
- Article
10
Correction to: Sublingual Dexmedetomidine for Agitation Associated with Schizophrenia or Bipolar Disorder: A Post Hoc Analysis of Number Needed to Treat, Number Needed to Harm, and Likelihood to be Helped or Harmed.
- Published in:
- 2023
- By:
- Publication type:
- corrected article
11
Phase 3 Study of Subcutaneous Versus Intravenous Ravulizumab in Eculizumab-Experienced Adult Patients with PNH: Primary Analysis and 1-Year Follow-Up.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 1, p. 211, doi. 10.1007/s12325-022-02339-3
- By:
- Publication type:
- Article
12
Peripheral T<sub>reg</sub> Levels and Transforming Growth Factor-β (TGFβ) in Patients with Psoriatic Arthritis: A Systematic Review Meta-Analysis.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 1, p. 102, doi. 10.1007/s12325-022-02337-5
- By:
- Publication type:
- Article
13
A Two-Step, Trajectory-Focused, Analytics Approach to Attempt Prediction of Analgesic Response in Patients with Moderate-to-Severe Osteoarthritis.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 1, p. 252, doi. 10.1007/s12325-022-02336-6
- By:
- Publication type:
- Article
14
Correction to: Patterns of Use and Clinical Outcomes with Long-Acting Somatostatin Analogues for Neuroendocrine Tumors: A Nationwide French Retrospective Cohort Study in the Real-Life Setting.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
15
Development of an Assessment Tool for Completion by Patients with Overweight or Obesity.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 1, p. 174, doi. 10.1007/s12325-022-02334-8
- By:
- Publication type:
- Article
16
Risk and Management of Bleeding Complications with Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Venous Thromboembolism: a Narrative Review.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 1, p. 41, doi. 10.1007/s12325-022-02333-9
- By:
- Publication type:
- Article
17
Cost-Effectiveness of Acthar Gel Versus Standard of Care for the Treatment of Exacerbations in Moderate-to-Severe Systemic Lupus Erythematosus.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 1, p. 194, doi. 10.1007/s12325-022-02332-w
- By:
- Publication type:
- Article
18
Identification and Validation of a Novel Glycolysis-Related Gene Signature for Predicting the Prognosis and Therapeutic Response in Triple-Negative Breast Cancer.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 1, p. 310, doi. 10.1007/s12325-022-02330-y
- By:
- Publication type:
- Article
19
Response to: Letter to the Editor Regarding Efficacy of IDegLira Versus IDegAsp Therapy in Patients with Type 2 Diabetes: A Randomized Crossover Study by isCGM.
- Published in:
- 2023
- By:
- Publication type:
- Letter
20
Letter to the Editor Regarding Efficacy of IDegLira Versus IDegAsp Therapy in Patients with Type 2 Diabetes: A Randomized Crossover Study by isCGM.
- Published in:
- 2023
- By:
- Publication type:
- Letter
21
Living with Chronic Kidney Disease and Type 2 Diabetes Mellitus: The Patient and Clinician Perspective.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 1, p. 1, doi. 10.1007/s12325-022-02325-9
- By:
- Publication type:
- Article
22
Advances in Delivery of Selective Internal Radiation Therapy (SIRT): Economic and Logistical Effects of Same-Stay Work-Up and Procedure in the Treatment of Unresectable Liver Tumors in England.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 1, p. 294, doi. 10.1007/s12325-022-02323-x
- By:
- Publication type:
- Article
23
No Increased Risk of Overall Infection in Adults with Moderate-to-Severe Atopic Dermatitis Treated for up to 4 Years with Dupilumab.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 1, p. 367, doi. 10.1007/s12325-022-02322-y
- By:
- Publication type:
- Article
24
A Review of Anti-IL-5 Therapies for Eosinophilic Granulomatosis with Polyangiitis.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 1, p. 25, doi. 10.1007/s12325-022-02307-x
- By:
- Publication type:
- Article
25
Educational and Emotional Needs of Patients with Myelodysplastic Syndromes: An AI Analysis of Multi-Country Social Media.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 1, p. 159, doi. 10.1007/s12325-022-02277-0
- By:
- Publication type:
- Article
26
Identifying Patients for Self-Administration of Omalizumab.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 1, p. 19, doi. 10.1007/s12325-022-02308-w
- By:
- Publication type:
- Article
27
Real-World Study of Regional Differences in Patient Demographics, Clinical Characteristics, and BRCA1/2 Mutation Testing in Patients with Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer in the United States, Europe, and Israel
- Published in:
- Advances in Therapy, 2023, v. 40, n. 1, p. 331, doi. 10.1007/s12325-022-02302-2
- By:
- Publication type:
- Article